financetom
PGNY
financetom
/
Healthcare
/
PGNY
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Progyny, Inc.PGNY
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.

Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.

In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015.

Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Latest News >
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Playtika Holding ( PLTK ) said Friday it formed a partnership to bring some of International Game Technology's ( IGT ) slot themes to Playtika's ( PLTK ) social casino games. IGT slot titles will appear in Playtika's ( PLTK ) Slotomania, Caesars Slots, and House of Fun beginning this month and heading...
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Dec 20, 2024
10:46 AM EST, 12/20/2024 (MT Newswires) -- Eshallgo ( EHGO ) is set to receive up to $20 million in equity investment in tranches from CS Asia Opportunities Master Fund, the companies said Friday. Under their securities purchase agreement, CS Fund will buy up to about 4.2 million shares of Eshallgo ( EHGO ) at $4.80 per share in tranches,...
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Dec 20, 2024
10:47 AM EST, 12/20/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said Friday morning that the US Food and Drug Administration has designated the company's VGT-1849A product candidate as an orphan drug to treat polycythemia vera, a rare form of hematologic malignancy affecting about one in every 2,000 people in the country. The FDA uses orphan drug designation to...
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Price: 904.23, Change: +2.19, Percent Change: +0.24 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved